About Clinigen
Clinigen is a company based in Burton Upon Trent (United Kingdom) founded in 2010 was acquired by Triton Partners in December 2021. Clinigen has completed 11 acquisitions, including Clinical Supplies Management, Drug Safety Navigator and IDIS Pharma. Clinigen offers products and services including Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs. Clinigen operates in a competitive market with competitors including Indegene, IntegriChain, Zuellig Pharma, Science Group and ClearView Healthcare Partners, among others.
- Headquarter Burton Upon Trent, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinigen Limited
- Date of Incorporation 12 Dec, 2008
- Jurisdiction BURTON ON TRENT, STAFFORDSHIRE
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Clinical Supplies Management
& 10 more
-
Acquired by
Triton Partners
(Dec 08, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clinigen
Clinigen offers a comprehensive portfolio of products and services, including Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs.
Services for sourcing, packaging, and distribution in clinical trials.
Programs for early access to innovative medicines for patients globally.
Support for pharmacovigilance and regulatory processes in medicine access.
People of Clinigen
Unlock access to complete
Unlock access to complete
Funding Insights of Clinigen
Detailed funding history for Clinigen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Clinigen
Clinigen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Triton Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt fund focused on service, healthcare, consumer, and industrial sectors
|
Locked | Locked | Locked |
Investor details for Clinigen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clinigen
Clinigen has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Clinical Supplies Management, Drug Safety Navigator and IDIS Pharma.
Investment portfolio details for Clinigen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Regulatory affairs, quality control, and medical monitoring services are provided.
|
Locked | Locked | 2012 | Locked | |
|
Pharmacovigilance and medical affairs services are offered for drug development.
|
Locked | Locked | 2010 | Locked | |
|
Provider of strategic development, regulatory affairs, and consultancy services for the biotech and pharmaceutical sectors
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Clinigen
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Clinigen
Detailed financials for Clinigen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinigen Comparisons
Peer comparison for Clinigen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clinigen
Clinigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Zuellig Pharma, Science Group and ClearView Healthcare Partners, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of Clinigen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinigen
Complete news archive for Clinigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clinigen
Clinigen was founded in 2010.
Clinigen is headquartered in Burton Upon Trent, United Kingdom. It is registered at Burton Upon Trent, England, United Kingdom.
Jerome Charton is the current CEO of Clinigen.
Clinigen Group was founded in 2010 and is based in Burton-on-Trent, United Kingdom. Operations are conducted in the specialty pharmaceutical and services sector through five businesses. Medicines are delivered to patients using clinical trials, licensed channels, and unlicensed pathways. Services encompass trial supplies, managed access to investigational drugs, global availability of approved medicines in limited regions, supply continuity for healthcare providers, and regional distribution of specialist products.
Clinigen's top competitors include Indegene, Zuellig Pharma and IntegriChain.
Clinigen offers Clinical Trial Supplies, Managed Access Programs, and Regulatory Affairs.
Clinigen has made 11 acquisitions, including Clinical Supplies Management, Drug Safety Navigator, and IDIS Pharma.
Clinigen has 1 investor. Key investors include Triton Partners.